+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Axillary Hyperhidrosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767630
  • Report
  • April 2019
  • Region: Global
  • 64 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Brickell Biotech Inc
  • Dermira Inc
  • DermResearch Inc
  • Dr. Wolff Gruppe GmbH
  • GlaxoSmithKline Plc
  • MORE
The global clinical trial report- “2019 Axillary Hyperhidrosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Axillary Hyperhidrosis. It presents in-depth analysis of Axillary Hyperhidrosis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Axillary Hyperhidrosis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Axillary Hyperhidrosis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Axillary Hyperhidrosis

The research work is prepared through extensive and continuous research on Axillary Hyperhidrosis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Axillary Hyperhidrosis patients are identified
  • The report includes panorama of Axillary Hyperhidrosis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Axillary Hyperhidrosis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Brickell Biotech Inc
  • Dermira Inc
  • DermResearch Inc
  • Dr. Wolff Gruppe GmbH
  • GlaxoSmithKline Plc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Axillary Hyperhidrosis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Axillary Hyperhidrosis Clinical Trials by Region
2.2.2 Average Enrollment of Axillary Hyperhidrosis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Axillary Hyperhidrosis Treatment, 2019

3. Region wise Axillary Hyperhidrosis Clinical Trials
3.1 Asia Pacific Axillary Hyperhidrosis Clinical Trials by Country
3.2 Europe Axillary Hyperhidrosis Clinical Trials by Country
3.3 North America Axillary Hyperhidrosis Clinical Trials by Country
3.4 Middle East and Africa Axillary Hyperhidrosis Clinical Trials by Country
3.5 South and Central America Axillary Hyperhidrosis Clinical Trials by Country

4. Axillary Hyperhidrosis Clinical Trial Trends
4.1 Start Year wise Axillary Hyperhidrosis Clinical Trials
4.2 Phase wise Axillary Hyperhidrosis Clinical Trials
4.3 Trial Status wise Axillary Hyperhidrosis Clinical Trials
4.4 Trial Type wise Axillary Hyperhidrosis Clinical Trials

5. Axillary Hyperhidrosis Average Enrollment Trends
5.1 Average Enrollment in Axillary Hyperhidrosis Trials by Year
5.2 Average Enrollment in Axillary Hyperhidrosis Trials by Phase
5.3 Average Enrollment in Axillary Hyperhidrosis Trials by Status
5.4 Average Enrollment in Axillary Hyperhidrosis Trials by Type of Trial

6. Companies Participating in Axillary Hyperhidrosis Clinical Trials
6.1 Axillary Hyperhidrosis Trials by Sponsor Type
6.2 Axillary Hyperhidrosis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Axillary Hyperhidrosis Trials- Phase 1
7.2 Axillary Hyperhidrosis Trials- Phase 2
7.3 Axillary Hyperhidrosis Trials- Phase 3
7.4 Axillary Hyperhidrosis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Axillary Hyperhidrosis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Axillary Hyperhidrosis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Axillary Hyperhidrosis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Axillary Hyperhidrosis Clinical Trials and Enrolment
Figure 7: North America - Country wise Axillary Hyperhidrosis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Axillary Hyperhidrosis Clinical Trials and Enrolment
Figure 9: Axillary Hyperhidrosis Clinical Trials by Phase
Figure 10: Axillary Hyperhidrosis Clinical Trials by Trial Status
Figure 11: Axillary Hyperhidrosis Clinical Trials by Type
Figure 12: Axillary Hyperhidrosis Clinical Trials by Sponsor Type
Figure 13: Axillary Hyperhidrosis Clinical Trials by Leading Sponsors
Figure 14: Axillary Hyperhidrosis Average Enrollment by Phase
Figure 15: Axillary Hyperhidrosis Average Enrollment by Trial Status
Figure 16: Axillary Hyperhidrosis Average Enrollment by Type
Figure 17: Axillary Hyperhidrosis- Average Enrolment by Type of Sponsors
Figure 18: Axillary Hyperhidrosis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Axillary Hyperhidrosis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Axillary Hyperhidrosis Clinical Trials and Enrolment
Table 5: Europe - Country wise Axillary Hyperhidrosis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Axillary Hyperhidrosis Clinical Trials and Enrolment
Table 7: North America - Country wise Axillary Hyperhidrosis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Axillary Hyperhidrosis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Axillary Hyperhidrosis Average Enrollment by Phase
Table 15: Axillary Hyperhidrosis Average Enrollment by Trial Status
Table 16: Axillary Hyperhidrosis Average Enrollment by Type
Table 17: Axillary Hyperhidrosis- Average Enrolment by Type of Sponsors
Table 18: Axillary Hyperhidrosis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Plc
  • Brickell Biotech Inc
  • Dermira Inc
  • DermResearch Inc
  • Dr. Wolff Gruppe GmbH
  • GlaxoSmithKline Plc
  • Kaken Pharmaceutical Co Ltd
  • Premier Research Group Ltd
  • Revance Therapeutics Inc
  • TKL Research Inc
Note: Product cover images may vary from those shown
Adroll
adroll